ASCO: oncologists rank Genentech "number one"

When asked which company stood out at last week's American Society of Clinical Oncology conference in Chicago, oncologists cited Genentech at the top of the list, according to AlphaDetail, a leader in oncology primary market research and influence network mapping solutions to the global life sciences industry.

In a brief on-line survey of 103 oncologists conducted soon after the close of the conference, AlphaDetail was able to gather some interesting feedback about oncologist perceptions of the meeting. The ASCO annual meeting attracts more than 30,000 attendees and is considered the premier educational and scientific event in the oncology community.